say statement may alreadi doubt
mean doesnt name like qualiti make definit
question qualiti hadnt clinton lost argument
said famou quot inhal
wba earn call stefano remind
never miss guidanc note
hypothes first two statement
current investor sentiment guidanc
best describ place think
cut whole rang other believ
cut bottom end rang
brought abrupt chang sentiment
ep call guid
ep growth constant currenc though
fx
competitor confer end march manag
note sever signific headwind compani face
includ heighten reimburs pressur less benefit
gener sourc tobacco challeng front end
click link analysi headwind
conclus given put take well mani
other lower ep estim
believ guidanc like see least
cut organ oi growth neg place like
outcom lower end prior rang
headwind like factor prior ton move part
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
stefano still would man word look
model contempl ep compound-annual-growth-rate
littl organ oper incom dollar growth let us
know youd like copi either model highli
detail ep bridg investor sentiment
see stock like move lower lower whole
rang mid-point move may squeez
keep low end rang feel free reach
headwind
tobacco challeng front end
current de-emphasize tobacco sale
better posit healthcar compani
stop sell tobacco sever year ago certain
state like new york mull ban tobacco
sale pharmaci mention wba recent
spate bad press sell tobacco kid
manag note de-emphasi could cost
bp fe sale decrement
less benefit gener sourc
reimburs quasi-perenni problem
drug store given increas pressur pbm
narrow network recent spate
reimburs pressur come chang
inflat well-com brand
inflat slow calendar email us
want data hsd msd note
portfolio inflat slow
index specialti given remuner
percentag awp lower brand inflat pressur
 estim slow brand inflat
hit happi send
ep bridge/calcul
abc gener sourc entiti
like less profit driver vs prior year
gener price deflat slow declin hsd
msd mayb even lsd price deflat
contribut lower acquisit cost like
due disciplin teva et al inabl
turn china altern suppli estim
increment headwind could ep hit
addit gener
penetr alreadi close fewer
impact opportun off-set price
headwind new gener launch
happen enjoy mix result exclus
margin hit ep although arguabl
correct decis
headwind partial off-set sever non-
share repurchas favor price cadenc
given wba current depress share price
seem lack larg deal around corner
repurchas prefer use
compani capit estim share
repurchas like rang
bn less mm option dilut
share price could result ep accret
plu addit impact follow
repurchas impli
tailwind ep growth vs guid would
impli off-set headwind
tax rate come favor
addit potenti tailwind
could come lower tax rate compani rate
fell bp add
go forward tax rate like
part qs last year
trend toward could addit
sourc upsid ep
tough environ uk
addit cost cut order februari
compani cut uk corpor job
total fall volum though reimburs
account uk busi vs
us poor consum sentiment brexit etc
weigh sale save gener
recycl back rejuven top boot
locat mostli citi center better
posit go forward net basi
restructur drive much ep
valuat methodolog base mix discount cash flow analysi rel valuat multipl
downsid risk potenti on-line competit amazon erod front end comp margin us
pharmaci share continu reimburs pressur us eu hit ultim lead total margin compress
transact prove challeng increas volum /revenu store appear futil lead poor return
posit independ retail us becom disadvantag vertic integr peer capabl take notabl
share manag unabl locat creativ transact leav balanc sheet underutil limit total oper
growth beauti push ultim becom distract momentum build manag must revisit costli rebuild
laboratori corp america
articl articl
time dissemin march
analyst elizabeth anderson suzi yoon ross muken primarili respons prepar research report attest
follow view opinion render research report reflect person view subject compani
issuer part research analyst compens directli relat specif recommend view
research report
